B-SOFT Co.,Ltd.: what insiders have been doing
This page follows insider dealings at B-SOFT Co.,Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. Nothing new has been filed by managers of B-SOFT Co.,Ltd. in twelve months, the latest record being from 4 January 2023.
Over the whole record (from 2021), the tally stands at no purchases and 4 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,800,000 shares100.0% of flowA股XSHESZSE:173000006181049020
- 9,200,000 shares16.2% of flowA股XSHESZSE:173000005520719580
- 1,626,816 shares4.4% of flowA股XSHESZSE:173000005190135580
- 29,259,390 shares79.5% of flowA股XSHESZSE:173000005188559970
4 of 4 declarations
About B-SOFT Co.,Ltd.
创业慧康 is a company in the health and pharmaceutical sector, listed on the XSHE market. It focuses on developing innovative solutions to enhance healthcare services.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
